glycine has been researched along with Cerebrovascular Disorders in 10 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using high-performance liquid chromatography, we determined the glutamate, aspartate, taurine, and glycine concentrations in the plasma and cerebrospinal fluid (CSF) of 128 patients with ischemic cerebral infarction confirmed by CT and 43 control subjects." | 3.69 | Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. ( Castillo, J; Dávalos, A; Naveiro, J; Noya, M, 1996) |
| "Homoarginine (hArg) is an endogenous, nonproteinogenic amino acid which differs from arginine by an additional methylene (CH2) group in the backbone." | 2.52 | Homoarginine in the renal and cardiovascular systems. ( Alesutan, I; Drechsler, C; Gaksch, M; Grübler, M; Hartaigh, BÓ; Lang, F; März, W; Meinitzer, A; Pilz, S; Tomaschitz, A; Verheyen, N; Voelkl, J, 2015) |
| " So far it is not clear whether NMDA receptor antagonists including glycine antagonists would be suitable for chronic administration because of their effects on cognition, learning and motor function." | 2.40 | The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications. ( Dannhardt, G; Kohl, BK, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilz, S | 1 |
| Meinitzer, A | 1 |
| Gaksch, M | 1 |
| Grübler, M | 1 |
| Verheyen, N | 1 |
| Drechsler, C | 1 |
| Hartaigh, BÓ | 1 |
| Lang, F | 1 |
| Alesutan, I | 1 |
| Voelkl, J | 1 |
| März, W | 1 |
| Tomaschitz, A | 1 |
| Jeanne, M | 1 |
| Gould, DB | 1 |
| Chuĭko, MR | 1 |
| Efremova, NM | 1 |
| Skvortsova, VI | 1 |
| Nishijima, S | 1 |
| Sugaya, K | 1 |
| Fukuda, T | 1 |
| Miyazato, M | 1 |
| Ashimine, S | 1 |
| Ogawa, Y | 1 |
| Castillo, J | 2 |
| Dávalos, A | 2 |
| Naveiro, J | 1 |
| Noya, M | 2 |
| Dannhardt, G | 1 |
| Kohl, BK | 1 |
| Marta Moreno, J | 1 |
| Lopez del Val, J | 1 |
| Morales Asin, F | 1 |
| Matsumura, M | 1 |
| Kuroda, M | 1 |
| Itoh, M | 1 |
| Hatakeyama, S | 1 |
| Haruki, K | 1 |
| Hirata, M | 1 |
| Koni, I | 1 |
| Takeda, R | 1 |
| Tofuku, Y | 1 |
| Barnes, DM | 1 |
3 reviews available for glycine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Homoarginine in the renal and cardiovascular systems.
Topics: Amidinotransferases; Animals; Biomarkers; Cerebrovascular Disorders; Energy Metabolism; Glycine; Hea | 2015 |
Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.
Topics: Amino Acid Substitution; Animals; Basement Membrane; Cerebrovascular Disorders; Collagen Type IV; Ge | 2017 |
The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications.
Topics: Alzheimer Disease; Animals; Binding Sites; Cerebrovascular Disorders; Epilepsy; Glycine; Humans; Neu | 1998 |
1 trial available for glycine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Efficacy and safety of glycine and limontar in the complex therapy of discirculatory encephalopathy and encephalopathy in diabetes mellitus type I].
Topics: Cerebrovascular Disorders; Citrates; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Combinat | 2010 |
6 other studies available for glycine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Cerebrovascular Disorders; Elec | 2006 |
Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aspartic Acid; Brain Ischemia; Cerebral Cortex | 1996 |
Progression of ischaemic stroke and excitotoxic aminoacids.
Topics: Aged; Cerebral Infarction; Cerebrovascular Disorders; Excitatory Amino Acids; Glutamic Acid; Glycine | 1997 |
Glycemia in the first stage after stroke: nutritional and fluid therapy influence.
Topics: Cerebrovascular Disorders; Enteral Nutrition; Fluid Therapy; Glycine; Humans | 1992 |
[Guanidino compounds in the elderly].
Topics: Aged; Aging; Bed Rest; Cerebrovascular Disorders; Diabetes Mellitus; Female; Glycine; Humans; Kidney | 1992 |
NMDA receptors trigger excitement.
Topics: Aspartic Acid; Brain; Brain Ischemia; Cell Survival; Cerebrovascular Disorders; Electrophysiology; G | 1988 |